Use of the Organ Donor with Prior Hepatitis B Infection: A Safe Option?

Fong T.L. , Bunnapradist S. , Jordan S.C. , Cho Y.W. Impact of hepatitis B core antibody status on outcomes of cadaveric renal transplantation: analysis of United Network of Organ Sharing database between 1994 and 1999. Transplantation 2002; 73: 85–9.

Rosenthal J.T. Expanded criteria for cadaver organ donation in renal transplantation. Urol Clin North Am 1994; 21: 283–92.

Gonzalez-Peralta R.P. , Andres J.M. , Tung F.Y. , Fang J.W. , Brunson M.E. , Davis G.L. , Lau J.N. Transplantation of a hepatitis B surface antigen-positive donor liver into a hepatitis B virus-negative recipient. Transplantation 1994; 58: 114–6.

Wolf J.L. , Perkins H.A. , Schreeder M.T. , Vincenti F. The transplanted kidney as a source of hepatitis B infection. Ann Intern Med 1979; 91: 412–4.

Mathurin P. , Mouquet C. , Poynard T. , Sylla C. , Benalia H. , Fretz C. , Thibault V. , Cadranel J.F. , Bernard B. , Opolon P. , Coriat P. , Bitker M.O. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29: 257–63.

Kairaitis L.K. , Gottlieb T. , George C.R. Fatal hepatitis B virus infection with fibrosing cholestatic hepatitis following renal transplantation. Nephrol Dial Transplant 1998; 13: 1571–3.

Rehermann B. , Ferrari C. , Pasquinelli C. , Chisari F.V. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2: 1104–8.

Brechot C. , Kremsdorf D. , Paterlini P. , Thiers V. Hepatitis B virus DNA in HBsAg negative patients: Molecular characterization and clinical implications. J Hepatol 1991; 13(suppl): S49–52.

Cabrerizo M. , Bartolomè J. , Caramelo C. , Barril G. , Carreno V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology 2000; 32: 116–23.

Hoofnagle J.H. , Seeff L.B. , Bales Z.B. , Zimmermann H.J. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978; 298: 1379–83.

Thiers V. , Kremsdorf D. , Schellekens H. , Goudeau A. , Sinski J. , Nakaijma E. , Mack D. , Driss F. , Wands J. , Tiollais P. , Brechot C. Transmission of hepatitis B from hepatitis B seronegative subjects. Lancet 1988; i: 1273–6.

Brechot C. , Thiers V. , Kremsdorf D. , Nalpas B. , Pol S. , Paterlini-Brechot C. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely “occult”? Hepatology 2001; 34: 194–203.

Dusheiko G. , Song E. , Bowyer S. , Whitcutt M. , Maier G. , Meyers A. , Kew M.C. Natural history of hepatitis B virus infection in renal transplant recipients - a fifteen-year follow-up. Hepatology 1983; 3: 330–6.

Nagington J. , Cossart Y.E. , Cohen B.J. Reactivation of hepatitis B after transplantation operations. Lancet 1977; i: 558–60.

Grotz W. , Rasenack J. , Benzing T. , Berthold H. , Peters T. , Walter E. , Schollmeyer P. , Rump L.C. Occurrence and management of hepatitis B virus reactivation following kidney transplantation. Clin Nephrol 1998; 49: 385–8.

Marcellin P. , Giostra E. , Martinot-Peignoux M. , Loriot M.A. , Jaegle M.L. , Wolf P. , Degott C. , Degos F. , Benhamou J.P. Redevelopment of hepatitis B surface antigen after renal transplantation. Gastroenterology 1991; 100: 1432–4.

Blanpain C. , Knoop C. , Delforge M.L. , Antoine M. , Peny M.O. , Liesnard C. , Vereerstraeten P. , Cogan E. , Adler M. , Abramowicz D. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies. Transplantation 1998; 66: 883–6.

Chazouilleres O. , Mamish D. , Kim M. , Carey K. , Ferrell L. , Roberts J.P. , Ascher N.L. , Wright T.L. “Occult” hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343: 142–6.

Dickson R.C. , Everhart J.E. , Lake J.R. , Wei Y. , Seaberg E.C. , Wiesner R.H. , Zetterman R.K. , Pruett T.L. , Ishitani M.B. , Hooofnagle J.H. , and The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology 1997; 113: 1668–74.

Wachs M. , Amend W.J. , Ascher N.L. , Bretan P.N. , Emond J. , Lake J.R. , Melzer H.S. , Roberts J.P. , Tomlanovich S.J. , Vincenti F. , Stock P. The risk of transmission of hepatitis B from HBsAg (-), HBcAb (+), HBIgM (-) organ donors. Transplantation 1995; 59: 230–4.

Kadian M. , Hawkins K. , Schwartz H. , Miller C. Use of hepatitis B core antibody-positive multi-organ donors. J Transplant Coord 1994; 4: 57–60.

Satterthwaite R. , Ozgu I. , Shibdan H. , Aswad S. , Sunga V. , Zapanta R. , Asai P. , Bogaard T. , Khetan U. , Mendez R.G. , Mendez R. Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors. Transplantation 1997; 64: 432–5.

Krieger N.R. , Vial C.M. , Millan M.T. , Imperial J. , Dafoe D.C. , Scandling J.D. Revisiting the use of hepatitis B core antibody-positive donor kidneys. Transplant Proc 2001; 33: 1535–6.

Madayag R.M. , Johnson L.B. , Bartlett S.T. , Schweitzer E.J. , Constantine N.T. , McCarter R.J. , Kuo P.C. , Keay S. , Oldach D.W. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease. Transplantation 1997; 64: 1781–6.